Back to UNITED CAPITAL FINANCIAL ADVISORS, LLC UNITED CAPITAL FINANCIAL ADVISORS, LLC

TGTXTGTX
10 quarters

Position history for UNITED CAPITAL FINANCIAL ADVISORS, LLCUNITED CAPITAL FINANCIAL ADVISORS, LLC's holdings in TG Therapeutics, Inc.

UNITED CAPITAL FINANCIAL ADVISORS, LLC previously held 0 shares of TGTX (TG Therapeutics, Inc.), worth $0 as of 2021-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$440,000

Total Shares Change

-59,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q2
Latest
Exited
0
-100.0%
$00.0%$37.61
0
2021-Q1
Increased
69,010
+0.0%
$3.3M0.0%$45.28
26
2020-Q4
Increased
69,005
+15.3%
$3.6M0.0%$52.89
31
2020-Q3
Decreased
59,865
-0.4%
$1.6M0.0%$26.17
0
2020-Q2
Increased
60,110
+8.6%
$1.2M0.0%$18.58
27
2020-Q1
Unchanged
55,360
0.0%
$545,0000.0%$10.32
0
2019-Q4
Decreased
55,360
-1.8%
$614,0000.0%$10.85
0
2019-Q3
Increased
56,400
+0.7%
$316,0000.0%$5.65
24
2019-Q2
Decreased
56,000
-5.1%
$484,0000.0%$8.65
0
2019-Q1
New
59,000
-
$440,0000.0%$8.04
33

Other major holders of TGTX: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used